2023
Dynamic Incidence of Typhoid Fever over a 10-Year Period (2010–2019) in Kibera, an Urban Informal Settlement in Nairobi, Kenya
Ng’eno E, Lind M, Audi A, Ouma A, Oduor C, Munywoki P, Agogo G, Odongo G, Kiplangat S, Wamola N, Osita M, Mugoh R, Ochieng C, Omballa V, Mogeni O, Mikoleit M, Fields B, Montgomery J, Gauld J, Breiman R, Juma B, Hunsperger E, Widdowson M, Bigogo G, Mintz E, Verani J. Dynamic Incidence of Typhoid Fever over a 10-Year Period (2010–2019) in Kibera, an Urban Informal Settlement in Nairobi, Kenya. American Journal Of Tropical Medicine And Hygiene 2023, 109: 22-31. PMID: 37253442, PMCID: PMC10324018, DOI: 10.4269/ajtmh.22-0736.Peer-Reviewed Original ResearchConceptsAntimicrobial resistanceBlood culturesSalmonella enterica serovar TyphiTyphoid fever incidencePrevalence of antimicrobial resistanceResistant to ciprofloxacinPeriods of low rateIncidence of typhoid feverLower respiratory infectionsAnnual crude incidenceHigher overall incidenceOverall incidenceAcute feverRespiratory infectionsCrude incidenceTyphoid feverEstimate crudeFever incidenceHigher incidenceIncidence rateChildren 5Fever burdenHousehold visitsPrevention strategiesLong-term data
2020
Trends in the Proportion of Time Spent Outpatient While Receiving Antibiotics for Treatment of Gram-Negative Rod Bacteremia Among Allogeneic Hematopoietic Cell Transplant Recipients
Lind M, Roncaioli S, Phipps A, Liu C, Bryant A, Sweet A, Pergam S. Trends in the Proportion of Time Spent Outpatient While Receiving Antibiotics for Treatment of Gram-Negative Rod Bacteremia Among Allogeneic Hematopoietic Cell Transplant Recipients. Transplantation And Cellular Therapy 2020, 26: s320-s321. DOI: 10.1016/j.bbmt.2019.12.343.Peer-Reviewed Original ResearchGram-negative rod bacteremiaAllogeneic HCT recipientsProportion of treatment timeHematopoietic cell transplantationMultidrug-resistant organismsHCT recipientsAllogeneic hematopoietic cell transplant recipientsInpatient intravenous antibiotic therapyAllogeneic hematopoietic cell transplantationHematopoietic cell transplant recipientsOutpatient settingIntravenous antibiotic therapySeverity of illnessMDR statusAntibiotic durationBlood culturesAntibiotic therapyCell transplantationTransplant recipientsReceiving antibioticsAdult patientsAntibiotic treatmentTreatment timeAntibiotic deliveryOutpatient management